Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial - Reuters
Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial Reuters
Eli Lilly Company News
Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial - BioPharma Dive
Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial BioPharma Dive
Building permit issued for $77M expansion at Eli Lilly manufacturing campus in Concord - The Business Journals
Building permit issued for $77M expansion at Eli Lilly manufacturing campus in Concord The Business Journals
Keystone Investors PTE Ltd. Makes New Investment in Eli Lilly and Company $LLY - MarketBeat
Keystone Investors PTE Ltd. Makes New Investment in Eli Lilly and Company $LLY MarketBeat
Lilly to acquire Orna Therapeutics to advance cell therapies | Eli Lilly and Company - Eli Lilly and Company
Lilly to acquire Orna Therapeutics to advance cell therapies | Eli Lilly and Company Eli Lilly and Company
RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market - Finviz
RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market Finviz
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch. - Business Insider
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch. Business Insider
Eli Lilly and Company $LLY is Harvest Portfolios Group Inc.'s 5th Largest Position - MarketBeat
Eli Lilly and Company $LLY is Harvest Portfolios Group Inc.'s 5th Largest Position MarketBeat
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance - Eli Lilly and Company
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance Eli Lilly and Company
Eli Lilly (LLY) Seen Resilient as BofA Downplays Novo Nordisk GLP-1 Price Impact - Finviz
Eli Lilly (LLY) Seen Resilient as BofA Downplays Novo Nordisk GLP-1 Price Impact Finviz
Eli Lilly and Company $LLY Position Boosted by Clal Insurance Enterprises Holdings Ltd - MarketBeat
Eli Lilly and Company $LLY Position Boosted by Clal Insurance Enterprises Holdings Ltd MarketBeat
Eli Lilly and Company (NYSE:LLY) Trading Up 2.8% Following Analyst Upgrade - MarketBeat
Eli Lilly and Company (NYSE:LLY) Trading Up 2.8% Following Analyst Upgrade MarketBeat
American Century Companies Inc. Acquires 120,905 Shares of Eli Lilly and Company $LLY - MarketBeat
American Century Companies Inc. Acquires 120,905 Shares of Eli Lilly and Company $LLY MarketBeat
TIAA Trust National Association Sells 6,331 Shares of Eli Lilly and Company $LLY - MarketBeat
TIAA Trust National Association Sells 6,331 Shares of Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company $LLY Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co - MarketBeat
Eli Lilly and Company $LLY Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co MarketBeat
Eli Lilly and Company $LLY Position Decreased by MGB Wealth Management LLC - MarketBeat
Eli Lilly and Company $LLY Position Decreased by MGB Wealth Management LLC MarketBeat
Integrated Advisors Network LLC Grows Stake in Eli Lilly and Company $LLY - MarketBeat
Integrated Advisors Network LLC Grows Stake in Eli Lilly and Company $LLY MarketBeat
Close Asset Management Ltd Has $43.54 Million Holdings in Eli Lilly and Company $LLY - MarketBeat
Close Asset Management Ltd Has $43.54 Million Holdings in Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company (NYSE:LLY) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Eli Lilly and Company (NYSE:LLY) Stock Price Expected to Rise, Guggenheim Analyst Says MarketBeat
Erste Asset Management GmbH Has $47.18 Million Holdings in Eli Lilly and Company $LLY - MarketBeat
Erste Asset Management GmbH Has $47.18 Million Holdings in Eli Lilly and Company $LLY MarketBeat
Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance | Eli Lilly and Company - Eli Lilly and Company
Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance | Eli Lilly and Company Eli Lilly and Company
How Novo Nordisk Lost Its Lead in the Weight-Loss Market - Bloomberg.com
How Novo Nordisk Lost Its Lead in the Weight-Loss Market Bloomberg.com
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama - Eli Lilly and Company
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama Eli Lilly and Company
Eli Lilly Just Delivered Fantastic News to Investors - The Motley Fool
Eli Lilly Just Delivered Fantastic News to Investors The Motley Fool
Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs - The Motley Fool
Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs The Motley Fool
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans - Eli Lilly and Company
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans Eli Lilly and Company
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas - Eli Lilly and Company
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas Eli Lilly and Company
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial - Eli Lilly and Company
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial Eli Lilly and Company
Lilly reports second-quarter 2025 financial results and raises guidance | Eli Lilly and Company - Eli Lilly and Company
Lilly reports second-quarter 2025 financial results and raises guidance | Eli Lilly and Company Eli Lilly and Company
Eli Lilly Becomes First Trillion-Dollar Health Company - HealthDay
Eli Lilly Becomes First Trillion-Dollar Health Company HealthDay
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI - Eli Lilly and Company
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI Eli Lilly and Company
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States - PR Newswire
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States PR Newswire
Robust Demand for Eli Lilly and Company (LLY)’s Obesity and Diabetes Treatments Drives Strong Investor Sentiment - Yahoo Finance
Robust Demand for Eli Lilly and Company (LLY)’s Obesity and Diabetes Treatments Drives Strong Investor Sentiment Yahoo Finance
Eli Lilly becomes first drugmaker to hit $1 trillion in market value - BioPharma Dive
Eli Lilly becomes first drugmaker to hit $1 trillion in market value BioPharma Dive
Latest Research: Eli Lilly and Co's Oral Weight-Loss Drug Orforglipron Demonstrates Superior Weight Loss Effects Compared to Semaglutide Tablets - 富途牛牛
Latest Research: Eli Lilly and Co's Oral Weight-Loss Drug Orforglipron Demonstrates Superior Weight Loss Effects Compared to Semaglutide Tablets 富途牛牛
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - Eli Lilly and Company
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases Eli Lilly and Company
Eli Lilly hits $1 trillion market value, a first in health care, as Novo Nordisk tumbles - CNBC
Eli Lilly hits $1 trillion market value, a first in health care, as Novo Nordisk tumbles CNBC
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity - Eli Lilly and Company
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity Eli Lilly and Company
Lilly and IU to expand access to clinical trials and latest innovative treatments for Hoosiers - News at IU
Lilly and IU to expand access to clinical trials and latest innovative treatments for Hoosiers News at IU
Eli Lilly Just Delivered Fantastic News to Shareholders - The Motley Fool
Eli Lilly Just Delivered Fantastic News to Shareholders The Motley Fool